American canine hepatozoonosis (ACH), caused by Hepatozoon americanum, is an emerging tick-borne disease of dogs. An indirect enzyme-linked immunosorbent assay (ELISA) that should facilitate diagnosis of infection and study of the epidemiology of ACH has been developed using H. americanum sporozoites as antigen. Efficacy of the new test as a diagnostic tool was compared with that of skeletal muscle biopsy, the current gold standard for confirming H. americanum infection. Results show that the test is sensitive (93%) and specific (96%) and that it is as reliable as histopathologic examination of skeletal muscle for detecting infection. The ELISA would be suitable as a routine laboratory test for diagnosis of ACH.
Canine hepatozoonosis was first described in India, with the causative organism classified as Leukocytozoon canis. 7 Later, the genus Hepatozoon was described, 14 and the dog parasite was subsequently transferred to this genus. 20 American canine hepatozoonosis (ACH) is an emerging tick-borne disease of dogs in the USA; 9 the New World parasite was described as a new species, H. americanum, based on the location of merogony in the vertebrate host and the severity of disease it produces in dogs. 19 Based on the structure of gamonts, H. americanum is similar to H. canis; 19 there is 96% genetic similarity between H. canis and H. americanum, based on 18S ribosomal RNA (rRNA) gene sequence data. 13 Hepatozoon americanum infections are characterized by a chronic, often fatal, disease in dogs. ACH was first reported from Texas 3 and then from Louisiana. 4 More recently, cases were reported from Oklahoma 16 and from Alabama and Georgia. 10 Dogs with ACH exhibit muscle wasting, weakness, leukocytosis with a mature neutrophilia, and periosteal bone proliferation. 3, 16, 18 The Gulf Coast tick (Amblyomma maculatum) is an excellent definitive host/vector for H. americanum. 12 Hepatozoon canis infection has long been diagnosed by demonstration of gamonts in circulating leukocytes. More recently, an indirect fluorescent antibody test has been developed that employs gamonts (recovered from buffy coat preparations) as antigen. 1 preliminarily on the basis of clinical signs and radiographic changes of bones; 15 confirmatory diagnosis requires demonstration of asexual stages of the parasite in skeletal muscle. 2, 16, 18 A serologic test would be a useful tool for routine laboratory diagnosis of H. americanum infections and should facilitate study of the epidemiology of the disease. Here, we describe an indirect enzyme-linked immunosorbent assay (ELISA) for the serologic diagnosis of H. americanum infection.
Materials and methods
Preparation of antigen for ELISA. Oocysts recovered from adult A. maculatum exposed to H. americanum as nymphs on a carrier dog served as the source of antigen for the indirect ELISA. Sporozoites were liberated from 1,000 oocysts by treating with dog bile. 11 Newly released sporozoites were washed 3 times with sterile phosphate-buffered saline (PBS), resuspended in 3 ml of sterile PBS, and subjected to ultrasonication for 5 min using an ultrasonicator a (settings: 9 output control, 90% duty cycle). The sonicated antigen was then diluted 100 times in PBS, and 100 l of diluted antigen/well was used to coat 96-well Immulon-2 flat-bottom microtiter plates, b which were incubated overnight at 37 C.
Preparation of antigen for adsorption. Before testing for ACH, it was necessary to adsorb serum samples with tick antigen to minimize the nonspecific binding of serum from animals that were suspected to have been exposed to ticks. Adsorption was accomplished using tick gut antigen. This antigen was prepared from tick gut that was isolated from 10 newly molted, unfed laboratory-reared adult A. maculatum. The gut material was ultrasonicated in 3 ml of PBS and centrifuged at 2,000 ϫ g for 2 min. The supernatant fluid was used as the antigen stock solution, and this stock solution was diluted 1:100 with PBS prior to being used to adsorb serum samples.
Source of serum samples. A total of 96 serum samples from 38 dogs and 18 coyotes were available for standard-izing the ELISA. Twenty-one of the 38 dogs were experimentally exposed animals; the remaining 17 were suspected of suffering from naturally occurring ACH. Two of the coyotes were experimentally inoculated with H. americanum. Serum samples were collected from dogs and coyotes experimentally exposed to H. americanum and from uninfected control dogs on a weekly basis. Other controls included serum samples from a cat infected with Cytauxzoon felis, a cow infected with Sarcocystis sp., and a cat infected with Toxoplasma gondii.
Adsorption of serum samples with tick antigen. All serum samples were adsorbed with tick gut antigen prior to being tested by ELISA for ACH. The serum samples were incubated with tick antigen at a 1:10 dilution for 1 hr at 37 C in a 1.5-ml microcentrifuge tube. After incubation, the serumtick antigen mixture was centrifuged at 5,000 ϫ g for 5 min to remove any antigen-antibody complexes, and the supernatant fluid was used for testing by ELISA.
ELISA Procedure. Antigen-coated plates were blocked with blocking solution (PBS containing 0.05% Tween-20
[PBST] and 2% fetal bovine serum) for 2 hr at 37 C. Serum samples were serially diluted (1:50, 1:100, 1:200, 1:400) in blocking solution, added to the wells in duplicate, and incubated for 1 hr at 37 C. Plates were then washed 4 times in PBST, after which they were incubated for 1 hr at 37 C with peroxidase-labeled anti-dog IgG c (or anti-bovine IgG c and anti-feline IgG c for cattle and cat sera, respectively) diluted in blocking solution (1:2,000). ELISA plates were then washed 4 times in PBST, and the substrate buffer containing the chromogen (tetramethylbenzidine c ) and the substrate (0.01% H 2 O 2 ) was added to the wells. After incubating at room temperature for 20 min on a plate shaker, color development was stopped by adding 25 l of 2 M sulfuric acid. Optical density (OD) readings were taken at 450 nm using an ELISA plate reader.
Statistical analysis. Only serum samples from laboratoryraised uninfected dogs (n ϭ 5), experimental dogs serving as controls (n ϭ 4), or dogs prior to experimental inoculation (n ϭ 12) were used as a ''gold standard'' for noninfected status. Two samples from each of the 4 negative control dogs were included, which were collected at the beginning of the experiment and approximately 3 wk later, corresponding to the time of sample collection from experimentally infected dogs. Negative muscle biopsy results from dogs suspected on the basis of clinical observation of having ACH and from wild-caught coyotes were considered insufficient evidence for serum samples to meet the noninfected gold standard requirements. Samples meeting the gold standard requirements for infected status came from experimentally infected dogs (n ϭ 8) and coyotes (n ϭ 2) in addition to 10 dogs with naturally occurring disease and 10 wild-caught coyotes. All 30 of these animals had positive muscle biopsy results, which is the gold standard for ACH. Descriptive statistics of test results were calculated using commercial statistical software. d Objective evaluation and selection of cutoff values for the ELISA test were achieved with the assistance of a specific analytical software e developed for evaluating quantitative diagnostic tests. 6 The determination of an optimal cutoff value was performed with the prevalence parameter set to 20% and a simplifying assumption that false-negative costs were equal to false-positive costs. 5 The kappa statistic f was used to evaluate the extent of agreement beyond chance between the gold standard classification and the ELISA results. Exact methods were used to calculate P-values for this statistical test. Agreement Ͼ80% was considered excellent. 8 The difference in mean OD values between dogs and coyotes classified as infected (gold standard) was evaluated with a t-test using a P-value of 0.05 as the level of significance.
After the cutoff point was established, the point estimates and 95% confidence intervals were calculated for the ELISA performance parameters (sensitivity, specificity, predictive value for positive [PVϩ] and negative [PVϪ] results) relative to the gold standard classification and sample prevalence rate using a commercial software. g The effect of varying disease prevalence on predictive values (PVϩ and PVϪ) was also determined. h
Results
Optimal dilution of serum for the ELISA. The optimal dilution was established by testing serum samples from naturally or experimentally infected dogs and coyotes and from uninfected control dogs. The optimal dilution was 1:200, the dilution at which the ratio of OD values from known positive sera to OD values from known negative sera was the highest.
Statistical analysis of the ELISA results. The OD values for the 96 serum samples ranged from 0.074 to 1.816. The mean OD value for gold standard positive samples from coyotes (1.338 Ϯ 0.065) was not significantly different from that of positive dogs (1.236 Ϯ 0.078) (P Ͼ 0.30). This result supported inclusion of serum samples from coyotes that had positive muscle biopsy results as part of the gold standard group. The OD values for the known infected (n ϭ 30) and noninfected (n ϭ 25) samples were normally distributed, with mean values of 1.277 and 0.542 and SDs of 0.294 and 0.233, respectively (P Ͼ 0.50 and P Ͼ 0.20, for normality).
Based on gold standard classifications, serum samples with OD values of Ն0.90 were considered positive; samples with OD values of Ͻ0.90 were negative. This optimal cutoff value was valid over a prevalence range of 14-54%, with the optimal cutoff value becoming larger or smaller as population prevalence parameters changed to values that were smaller or larger, respectively, than these specified range limits. All ELISA results and subsequent evaluations were interpreted using the OD cutoff value of 0.90.
The ELISA results were compared with those of serum samples classified by the gold standard ( Table  1 ). The ELISA was 94.5% accurate, incorrectly classifying 3 of 55 samples designated by the gold standard. Two dogs with naturally occurring disease that had positive muscle biopsy results yielded false-neg- ative ELISA results (OD ϭ 0.534 and 0.872). One negative control dog had a serum sample with a high OD value of 1.132 and thus a false-positive ELISA result. A receiver operating characteristic curve comparing ELISA sensitivity against false-positive error rate showed very favorable test performance, with an area under the curve of 97.33%, approaching the ideal value of 100%.
The ELISA performance was evaluated according to measurements of test sensitivity, specificity, and predictive values for positive and negative test results ( Table 2 ). These point estimates for performance parameters were developed from the 55 reference serum samples from dogs and coyotes with known infected or noninfected disease status. The sensitivity was 93%, providing a false-negative test rate of 7% for infected dogs or coyotes. The specificity was 96%, which would give a false-positive test rate of 4% for noninfected animals. The effect of varying levels of disease prevalence on predictive values for positive and negative test results is shown in Fig. 1 . As presumed prevalence levels dropped below 15% or rose above 85%, sharp declines occurred in the corresponding values for positive and negative predictive values, respectively.
Five of the 8 coyotes and all 7 dogs suspected of having ACH but were negative based on the ELISA also had negative muscle biopsy results. The 3 coyotes that had apparently conflicting ELISA results were low positives, with OD values ranging from 0.920 to 1.040, i.e., close to the cutoff value of 0.90. The remaining 26 of the 96 samples were obtained from either negative control (n ϭ 8) or experimentally infected (n ϭ 18) dogs from whom samples were collected weekly between 1 and 3 weeks postinoculation. All of the samples from negative control dogs remained negative (mean Ϯ SD OD ϭ 0.579 Ϯ 0.109) throughout the testing period. The samples from dogs that were incubating infections gave mixed results at 11 days (10 negative and 2 positive), with OD values from 0.610 to 1.475. One sample collected at 14 days was negative (OD ϭ 0.685); the remaining 9 samples from other experimentally exposed dogs collected at 16-21 days were all positive, with OD values ranging from 1.010 to 1.783. All experimentally infected dogs for which samples were available through 3 weeks postexposure became seropositive. No sample was available from dog 3307 after week 2. There was no cross-reaction when serum samples from animals infected with Cytauxzoon, Sarcocystis, and Toxoplasma were tested with the new ELISA.
Discussion
An indirect ELISA was used for the first time for serologic diagnosis of H. americanum infection. Antigen for the ELISA was prepared from sporozoites of H. americanum that developed in the invertebrate host, A. maculatum. Successful experimental infections of this tick and consistently high infection rates 11, 12 of the ticks made development of this test possible. Sporozoites from experimentally infected ticks are an ideal source of antigen because they are the infective stages that are first exposed to the vertebrate host immune system.
Utilizing bile to stimulate release of sporozoites from sporocysts facilitated obtaining relatively clean preparations of antigen with little contamination with tick tissues. Presence of even small amounts of tick tissue in the antigen preparation will result in unacceptable levels of nonspecific binding if serum samples contain antibodies against tick antigen. Adsorbing serum samples with preparations of tick gut was adequate for eliminating nonspecific antibody binding.
Unlike H. canis infections in dogs, diagnosis of ACH has been difficult owing to the low parasitemia that characterizes ACH. Histopathologic examination of skeletal muscle is currently the accepted gold standard for confirmatory diagnosis of the disease. When compared with muscle biopsy results, the ELISA had high levels of sensitivity (93%) and specificity (96%), making this serologic test essentially as reliable as muscle biopsy unless dogs that eliminate infection retain seropositivity. The ELISA should be suitable for the routine laboratory diagnosis of ACH. In the diagnostic setting, to account for the possible 7% falsenegative rate, muscle biopsy should be performed in all situations where clinical signs are suggestive of ACH but the ELISA is negative.
Others 15 have shown that parasites could be detected by examination of skeletal muscle biopsies in experimentally exposed dogs and coyotes 3-4 weeks after exposure. In experimentally infected canids, seroconversion was detected with the ELISA 2-3 weeks after exposure. It is not known precisely when antibodies against H. americanum first appear in the serum of experimentally exposed dogs or coyotes, but serum samples that were collected from dogs at 2 and 3 weeks after exposure to H. americanum oocysts had antibodies detectable by ELISA. Daily sampling of dogs after experimental exposure would be required to clarify this matter.
With 2 exceptions, all 10 dogs naturally infected with H. americanum (as confirmed by muscle biopsy) were seropositive by ELISA. These 2 exceptions were originally diagnosed (by muscle biopsy) with ACH in 1996 (1 dog survived until 1998 and the other is still alive in 2000), but no serum samples were collected for testing until 1998. It is not known why these dogs were seronegative by the new test, but it is speculated that if dogs become chronic carriers, serum antibodies against sporozoites may decay. Another possible explanation for the false-negative results is that these dogs underwent continuous, long-term nonsteroidal anti-inflammatory drug therapy, which may have contributed to lack of detectable antibodies.
The ELISA should be useful as a tool for the epidemiological investigation of ACH. Extensive studies are needed to determine the natural endemic cycle of this parasite. Dogs are probably accidentally inserted into an enzootic cycle that involves A. maculatum and some vertebrate host for H. americanum when they ingest infected ticks while grooming or when they ingest prey animals that have infected ticks on them. This serologic test should be useful not only in diagnosing disease in domestic dogs, but also in investigating the vertebrate host range of this parasite in the wild.
